vimarsana.com
Latest Breaking News On - Favorable safety data - Page 1 : vimarsana.com
Clearside Biomedical Announces Positive 6-Month Results
- Suprachoroidal CLS-AX Resulted in Favorable Safety Data, Durability and Biologic Effect Over 6 Months in Treatment-Experienced Anti-VEGF Sub-Responders -.
Phoenix
Arizona
United-states
University-of-arizona
Markr-barakat
Thomasa-ciulla
George-lasezkay
Retinal-research-institute
University-of-arizona-college-medicine
Nasdaq
Clearside-biomedical-inc
Favorable-safety-data
vimarsana © 2020. All Rights Reserved.